Cambridge Investment Research Advisors’s Goldman Sachs Equal Weight US Large Cap Equity ETF GSEW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Sell
11,522
-28,581
-71% -$2.6M ﹤0.01% 2240
2026
Q1
$3.4M Buy
40,103
+12,728
+46% +$1.11M 0.01% 1208
2025
Q4
$2.33M Buy
27,375
+4,773
+21% +$405K 0.01% 1403
2025
Q3
$1.92M Buy
+22,602
New +$1.89M 0.01% 1540
2022
Q4
Sell
-3,860
Closed -$206K 3152
2022
Q3
$206K Sell
3,860
-3,503
-48% -$206K ﹤0.01% 2681
2022
Q2
$409K Buy
+7,363
New +$448K ﹤0.01% 2120

Other funds holding GSEW

Cambridge Investment Research Advisors's GSEW Position: Q2 2026 in Review

Cambridge Investment Research Advisors reduced its Goldman Sachs Equal Weight US Large Cap Equity ETF (GSEW) stake by 71% in Q2 2026, selling an estimated $2.6M and leaving 11,522 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2240.

Cambridge Investment Research Advisors first reported a position in GSEW in Q2 2022 and has held it in 6 quarters since. The position peaked at $3.4M in Q1 2026. 182 funds tracked by Wall St. Rank hold GSEW as of Q2 2026.

  • Cambridge Investment Research Advisors held 11,522 shares of Goldman Sachs Equal Weight US Large Cap Equity ETF worth $1.09M as of Q2 2026.
  • Cambridge Investment Research Advisors sold 28,581 Goldman Sachs Equal Weight US Large Cap Equity ETF shares in Q2 2026, an estimated $2.6M.
  • Goldman Sachs Equal Weight US Large Cap Equity ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #2240 holding.
  • Cambridge Investment Research Advisors first reported a position in Goldman Sachs Equal Weight US Large Cap Equity ETF in Q2 2022 and has held it in 6 quarters since.
  • Cambridge Investment Research Advisors's Goldman Sachs Equal Weight US Large Cap Equity ETF position peaked at $3.4M in Q1 2026.
  • 182 funds tracked by Wall St. Rank held Goldman Sachs Equal Weight US Large Cap Equity ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.